ULTRAGENYX PHARMACEUTICAL
Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective development strategies are essential for success in the rare disease space, in which information may be incomplete or ambiguous, and few development precedents exist. The management team's experience in selecting and developing products with clear mechanisms of action for untreated rare diseases will help Ultragenyx create life-changing therapeutics by leveraging existing yet undeveloped science for these little-known indications.
ULTRAGENYX PHARMACEUTICAL
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2010-01-01
Address:
Novato, California, United States
Country:
United States
Website Url:
http://www.ultragenyx.com
Total Employee:
501+
Status:
Active
Contact:
+1 415 483 8800
Total Funding:
1.14 B USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta Euro Apple Mobile Web Clips Icon Google Font API Google Tag Manager WordPress Content Delivery Network Amazon Font Awesome
Similar Organizations
Aeovian Pharmaceuticals
Aeovian Pharmaceuticals aims to discover, develop, and commercialize therapeutics for the treatment of rare and age-related diseases.
Dicerna Pharmaceuticals
Dicerna Pharmaceuticals is a biotechnology company with a focus on the development of innovative treatments for rare inherited diseases.
Mithra Pharmaceuticals SA
Mithra Pharmaceuticals SA specializes in the development of women's health care products.
Sonoma Pharmaceuticals
Sonoma Pharmaceuticals develops and markets a global array of treatments for dermatological conditions and advanced tissue care.
EyePoint Pharmaceuticals
EyePoint Pharmaceuticals specializes in the development and commercialization of ophthalmic products for the treatment of eye diseases.
Santhera Pharmaceuticals
Santhera Pharmaceuticals develops and markets pharmaceutical products for the treatment of mitochondrial and neuromuscular diseases.
Surrozen
Surrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.
Versiti
Versiti provide innovative, value added solutions in the fields of transfusion medicine, transplantation, and blood-related diseases.
Vertex Pharmaceuticals
Vertex Pharmaceuticals is focused on the discovery and development of small molecule drugs for the treatment of serious diseases.
AlloVir
AlloVir focuses on the development of cell therapies and focuses on restoring natural immunity against the virus-associated diseases.
Current Advisors List
Board_member
Board_member
Board_member
Current Employees Featured
Kenneth Lowe Director @ Ultragenyx Pharmaceutical
Director
2022-03-01
Yael Weiss VP Business Development @ Ultragenyx Pharmaceutical
VP Business Development
2017-04-01
Howard Horn Executive Vice President and CFO @ Ultragenyx Pharmaceutical
Executive Vice President and CFO
2023-01-01
Christine Murray Senior Advisor, Development @ Ultragenyx Pharmaceutical
Senior Advisor, Development
2021-09-01
John Pinion EVP Translational Sciences, Chief Quality Operations Officer @ Ultragenyx Pharmaceutical
EVP Translational Sciences, Chief Quality Operations Officer
Carolyn Wang SVP, Global Corporate Communications @ Ultragenyx Pharmaceutical
SVP, Global Corporate Communications
2021-05-01
Dennis Huang Chief Technical Operations Officer; EVP Gene Therapy Operations @ Ultragenyx Pharmaceutical
Chief Technical Operations Officer; EVP Gene Therapy Operations
Yael Weiss Executive Director, Search and Evaluation, Business Development @ Ultragenyx Pharmaceutical
Executive Director, Search and Evaluation, Business Development
2014-11-01
Thomas Kassberg Chief Business Officer and Senior Vice President @ Ultragenyx Pharmaceutical
Chief Business Officer and Senior Vice President
Ted Huizenga Chief Accounting Officer @ Ultragenyx Pharmaceutical
Chief Accounting Officer
2022-01-01
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2022-07-18 | GeneTx Biotherapeutics | GeneTx Biotherapeutics acquired by Ultragenyx Pharmaceutical | 75 M USD |
| 2017-09-18 | Dimension Therapeutics | Dimension Therapeutics acquired by Ultragenyx Pharmaceutical | 152.3 M USD |
Investors List
Takeda Ventures
Takeda Ventures investment in Post-IPO Equity - Ultragenyx Pharmaceutical
Takeda
Takeda investment in Post-IPO Equity - Ultragenyx Pharmaceutical
F-Prime Capital
F-Prime Capital investment in Series B - Ultragenyx Pharmaceutical
Adage Capital Management
Adage Capital Management investment in Series B - Ultragenyx Pharmaceutical
HealthCap
HealthCap investment in Series B - Ultragenyx Pharmaceutical
Pappas Ventures
Pappas Ventures investment in Series B - Ultragenyx Pharmaceutical
TPG Growth
TPG Growth investment in Series B - Ultragenyx Pharmaceutical
BlackRock Private Equity Partners
BlackRock Private Equity Partners investment in Series B - Ultragenyx Pharmaceutical
HealthCap
HealthCap investment in Series A - Ultragenyx Pharmaceutical
F-Prime Capital
F-Prime Capital investment in Series A - Ultragenyx Pharmaceutical
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2020-10-23 | Solid Biosciences | Ultragenyx Pharmaceutical investment in Post-IPO Equity - Solid Biosciences | 40 M USD |
Newest Events participated
Key Employee Changes
| Date | New article |
|---|---|
| 2023-07-12 | Ultragenyx Pharmaceutical appoints CFO |
| 2023-03-14 | Ultragenyx Appoints Dr. Eric Crombez Chief Medical Officer and Executive Vice President |
| 2022-11-10 | Ultragenyx Announces Departure of Chief Financial Officer |
Official Site Inspections
http://www.ultragenyx.com Semrush global rank: 1.03 M Semrush visits lastest month: 26.72 K
- Host name: 104.18.27.199
- IP address: 104.18.27.199
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Ultragenyx Pharmaceutical"
Ultragenyx—Treatment of Rare and Ultrarare Genetic …
“Ultragenyx was founded to advance innovative medicines for rare and ultrarare diseases that have never been treated before. We are delivering transformative therapies across multiple indications, and we have one of the most robust and …See details»
Ultragenyx - Wikipedia
Ultragenyx Pharmaceutical Inc. was founded in 2010 by Emil Kakkis based on his history of developing therapies for rare disease starting at Harbor-UCLA Medical Center, continuing …See details»
Corporate Responsibility—Ultragenyx
*A subset of the employee engagement survey—focused on employee pride in our company, whether an employee would recommend Ultragenyx as a good place to work, whether an employee experiences a feeling of personal …See details»
Ultragenyx Pharmaceutical - Crunchbase Company …
Ultragenyx Pharmaceutical develops therapeutics for rare diseases, sometimes referred to as Orphan products. Ultragenyx is a efficient and effective …See details»
Ultragenyx Reports First Quarter 2025 Financial Results and …
1 day ago Except for the historical information contained herein, the matters set forth in this press release, including statements related to Ultragenyx's expectations and projections …See details»
Michael Narachi—Ultragenyx
Mr. Narachi is a member of the Ultragenyx Board of Directors. To transform the lives of as many people living with rare diseases as possible, we dedicate ourselves every day to the …See details»
ULTRAGENYX PHARMACEUTICAL INC
Of such organization or company could be competitive with the Company, or otherwise impact the Company in a material manner. Upon receipt of such notice, the Chair of the Nominating and …See details»
Ultragenyx Pharmaceutical Inc Company Profile - Overview
Ultragenyx Pharmaceutical Inc (Ultragenyx) is a biotechnology company that develops novel medicines for rare and ultra-rare genetic diseases. It has four marketed products, Mepsevii …See details»
Ultragenyx Company Profile | Management and Employees List
Ultragenyx's product pipeline includes treatments for metabolic disorders, bone diseases, and enzyme deficiencies. The company operates globally with a strong presence in North America, …See details»
Ultragenyx Patient Advocacy - Rare and UltraRare …
Ultragenyx Advocacy. Our Advocacy Team; Follow Us. Follow us on Facebook Follow us on LinkedIn. In the company of parents, protectors, and proud partners in care. Where are you in your rare journey? The rare community is made up …See details»
Understanding Gene Therapy - Ultragenyx
What are Ultragenyx’s gene therapies in development? Our mission is to address the root cause of these genetic diseases, not just the symptoms, helping to slow down or stop disease …See details»
Ultragenyx’s Corporate Sustainability Journey
Nov 22, 2022 Ultragenyx was founded in 2010 to develop medicines for rare and ultrarare diseases and a core ethos to treat as many rare disease patients as possible. As we …See details»
Ultragenyx - PharmaSource
Ultragenyx is committed to transforming the lives of patients with rare and ultra-rare diseases by delivering innovative therapies where none previously existed. Their dedication to scientific …See details»
Ultragenyx CEO Emil Kakkis: ‘Our Future Is In Our Hands’
Mar 24, 2025 The founder and CEO of Ultragenyx talked with Scrip as the company approaches a pivotal data readout and awaits US FDA action on its first gene therapy. Related Companies. …See details»
Ultragenyx, a Rare Disease Powerhouse in Less Than 15 Years
Oct 30, 2024 Focused on rare and ultra-rare genetic diseases, Ultragenyx identifies itself as the industry’s most productive company working in the field of high un-met need diseases. With no …See details»
Ultragenyx Company Profile - Office Locations, Competitors, …
Oct 28, 2024 Ultragenyx has 5 employees across 15 locations and $560.23 m in annual revenue in FY 2024. See insights on Ultragenyx including office locations, competitors, revenue, …See details»
Ultragenyx Reports First Quarter 2025 Financial Results and …
15 hours ago Ultragenyx reported $139 million in total revenue for the first quarter of 2025, which represents 28% growth compared to the same period in 2024. First quarter 2025 Crysvita …See details»
Working at Ultragenyx - Top Workplaces
An inclusive culture of value and respect Ultragenyx brings novel products to those living with rare and ultrarare diseases with a focus on debilitating genetic diseases. Founded in 2010, the …See details»
Our Culture—Ultragenyx
These groups help drive awareness about important inclusion and belonging topics while inspiring positive change within Ultragenyx and beyond. Community groups are created with the …See details»
How Does Ultragenyx Pharmaceutical Work?
Nov 30, 2024 Ultragenyx Pharmaceutical generates revenue through various streams that are essential for the growth and sustainability of the company. These revenue streams are …See details»